Switch to:
More From Other Websites
Failed Mergers Cast Shadow on Sanofi's Future Jan 23 2017
Regeneron Pharmaceuticals Could Be Ready to Rebound Jan 20 2017
These Insiders Are Still Finding Some Good Value in the Stock Market Jan 19 2017
Regeneron, Sanofi Claim Amgen's LDL-Buster Patent Too Broad Jan 17 2017
Key FDA Events to Watch Out for in Q1 Jan 17 2017
Odds Are Against Regeneron, Sanofi In Amgen Patent Battle: Leerink Jan 13 2017
Regeneron, Sanofi's Drug Manufacturing Plant Cleared Jan 12 2017
Merrill Lynch Has 4 Red-Hot Stocks to Buy With Up to 75% Upside Potential Jan 12 2017
Trump's Comments Are Big Pharma's Nightmare Jan 11 2017
Trump's Comments Are Big Pharma's Nightmare Jan 11 2017
Todd Hagopian's Top Biotech Takeover Targets For 2017 Jan 10 2017
Regeneron CEO: The industry doesn't put patients first Jan 10 2017
The Zacks Analyst Blog Highlights: Clovis Oncology, Pfizer, Roche's, Sanofi and Regeneron... Jan 10 2017
Amgen Inks Multiple Deals, Offers Update on Repatha Lawsuit Jan 10 2017
Regeneron CEO says Amgen not putting patients first in patent dispute Jan 09 2017
Regeneron CEO says Amgen not putting patients first in patent dispute Jan 09 2017


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK